Company: PBH
Filing Date: 2025-05-08
Form Type: 8-K
Source: 0001295947-25-000014
Chunk: 0

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-08
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On May 8, 2025, Prestige Consumer Healthcare Inc. (the “ Company”) announced financial results for the fiscal quarter and year ended March 31, 2025. A copy of the press release announcing the Company's earnings results for the fiscal quarter and year ended March 31, 2025 is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On May 8, 2025, representatives of the Company began making presentations to investors regarding the Company's financial results for the quarter and year ended March 31, 2025, using slides containing the information attached to this Current Report on Form 8-K as Exhibit 99.2 (the “ Investor Presentation”) and incorporated here in by reference. The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others during the fiscal year ended March 31, 2026.

By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission (“ SEC”) filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

The information presented in Items 2.02 and 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item